Latest filing published 03 Sept 2026 for Fulgent Genetics, Inc., €28k.
Hanlin Gao, listed as senior executive, appears in our data through filings on Fulgent Genetics, Inc. shares, published by SEC (Form 4). We count 74 filings; the first trade dates from 1 August 2019 and the latest from 2 September 2026.
On the market, this insider has only sold: 29 sales, €578k in total. The rest of the record consists of 43 share grants. In 2026 alone, the filings show no purchases and 3 sales.
The newest entry dates from 3 September 2026: an open-market sale of €28k, in Fulgent Genetics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 74 declarations